HEPA - Hepion Pharmaceuticals, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
Edison,
United States
Type: Equity
HEPA price evolution
HEPA
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $14.79 | $19.28 | $30.52 | $42.99 |
| Short term investments | ||||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $17.49 | $21.27 | $32.76 | $45.81 |
| Long term investments | ||||
| Property, plant & equipment | $0.24 | $0.28 | $0.06 | $0.06 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $0.61 | $3.73 | $3.74 | $3.69 |
| Total investments | ||||
| Total assets | $18.09 | $25 | $36.5 | $49.5 |
| Current liabilities | ||||
| Accounts payable | $2.35 | $3.01 | $4.19 | $3.17 |
| Deferred revenue | ||||
| Short long term debt | $0.12 | $0.11 | ||
| Total current liabilities | $5.29 | $6.4 | $7.67 | $9.8 |
| Long term debt | $0.09 | $0.13 | ||
| Total noncurrent liabilities | $5.52 | $2.44 | $2.46 | $2.54 |
| Total debt | $0.21 | $0.24 | ||
| Total liabilities | $10.81 | $8.84 | $10.13 | $12.34 |
| Shareholders' equity | ||||
| Retained earnings | -$224.63 | -$213.57 | -$203.04 | -$188.96 |
| Other shareholder equity | -$0.08 | -$0.09 | -$0.09 | -$0.07 |
| Total shareholder equity | $7.28 | $16.16 | $26.37 | $37.15 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $14.79 | $51.19 | $91.35 | $40.73 |
| Short term investments | ||||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $17.49 | $56.5 | $97.45 | $42.63 |
| Long term investments | ||||
| Property, plant & equipment | $0.24 | $0.13 | $0.46 | $0.66 |
| Goodwill & intangible assets | $1.87 | $1.87 | ||
| Total noncurrent assets | $0.61 | $3.75 | $6.1 | $6.01 |
| Total investments | ||||
| Total assets | $18.09 | $60.24 | $103.55 | $48.65 |
| Current liabilities | ||||
| Accounts payable | $2.35 | $2.67 | $2.45 | $3.72 |
| Deferred revenue | ||||
| Short long term debt | $0.12 | $0.05 | $0.27 | $0.28 |
| Total current liabilities | $5.29 | $7.89 | $8.21 | $4.66 |
| Long term debt | $0.09 | $0.05 | $0.47 | |
| Total noncurrent liabilities | $5.52 | $2.5 | $2.35 | $3.46 |
| Total debt | $0.21 | $0.05 | $0.32 | $0.75 |
| Total liabilities | $10.81 | $10.39 | $10.56 | $8.12 |
| Shareholders' equity | ||||
| Retained earnings | -$224.63 | -$175.7 | -$133.5 | -$104.11 |
| Other shareholder equity | -$0.08 | -$0.09 | $0.86 | |
| Total shareholder equity | $7.28 | $49.86 | $93 | $40.52 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $5.44 | $8.52 | $11.88 | $9.8 |
| Selling, general & administrative | $1.78 | $2.15 | $2.28 | $3.41 |
| Total operating expenses | $10.41 | $10.66 | $14.17 | $13.21 |
| Operating income | -$10.41 | -$10.66 | -$14.17 | -$13.21 |
| Income from continuing operations | ||||
| EBIT | -$11.47 | -$10.52 | -$14.08 | -$13.26 |
| Income tax expense | -$0.41 | |||
| Interest expense | $0 | $0 | $0 | $0 |
| Net income | ||||
| Net income | -$11.06 | -$10.53 | -$14.08 | -$13.26 |
| Income (for common shares) | -$11.06 | -$10.53 | -$14.08 | -$13.26 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $35.64 | $33.27 | $20.4 | $12 |
| Selling, general & administrative | $9.62 | $10.35 | $10.01 | $8.15 |
| Total operating expenses | $48.45 | $45.49 | $30.4 | $20.15 |
| Operating income | -$48.45 | -$45.49 | -$30.4 | -$20.15 |
| Income from continuing operations | ||||
| EBIT | -$49.33 | -$45.07 | -$32.71 | -$20.29 |
| Income tax expense | -$0.41 | -$2.88 | $0.03 | |
| Interest expense | $0.01 | $0.01 | $0.01 | $0.03 |
| Net income | ||||
| Net income | -$48.93 | -$42.2 | -$32.72 | -$20.35 |
| Income (for common shares) | -$48.93 | -$45.34 | -$32.72 | -$20.36 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$11.06 | -$10.53 | -$14.08 | -$13.26 |
| Operating activities | ||||
| Depreciation | $0.01 | $0.02 | $0.02 | $0.02 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.15 | $0.32 | -$1.06 | $1.93 |
| Total cash flows from operations | -$9 | -$11.24 | -$12.44 | -$8.21 |
| Investing activities | ||||
| Capital expenditures | -$0 | $0 | -$0.02 | |
| Investments | ||||
| Total cash flows from investing | -$0 | $0 | -$0.02 | |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $4.49 | |||
| Net borrowings | ||||
| Total cash flows from financing | $4.49 | |||
| Effect of exchange rate | $0.01 | -$0 | -$0.02 | $0.02 |
| Change in cash and equivalents | -$4.5 | -$11.24 | -$12.47 | -$8.2 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$48.93 | -$42.2 | -$32.72 | -$20.35 |
| Operating activities | ||||
| Depreciation | $0.07 | $0.08 | $0.09 | $0.03 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $1.34 | $2.55 | $4.67 | $2.38 |
| Total cash flows from operations | -$40.89 | -$34.96 | -$31.22 | -$16.17 |
| Investing activities | ||||
| Capital expenditures | -$0.01 | -$0.01 | -$0.13 | -$0.09 |
| Investments | ||||
| Total cash flows from investing | -$0.01 | -$0.01 | -$0.13 | -$0.09 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $4.49 | $82.15 | $42.88 | |
| Net borrowings | -$0.18 | $0.18 | ||
| Total cash flows from financing | $4.49 | -$5.14 | $81.98 | $43.05 |
| Effect of exchange rate | $0.01 | -$0.05 | ||
| Change in cash and equivalents | -$36.4 | -$40.16 | $50.62 | $26.8 |
News
Fundamentals
| Market cap | $6.07M |
|---|---|
| Enterprise value | -$8.51M |
| Shares outstanding | 4.82M |
| Revenue | $0.00 |
|---|---|
| EBITDA | -$49.26M |
| EBIT | -$49.33M |
| Net Income | -$48.93M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | -0.12 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | 0.17 |
| EV/EBIT | 0.17 |
| P/S ratio | N/A |
| P/B ratio | 0.82 |
| Book/Share | 1.53 |
| Cash/Share | 3.07 |
| EPS | -$10.15 |
|---|---|
| ROA | -151.60% |
| ROE | -225.04% |
| Debt/Equity | 1.49 |
|---|---|
| Net debt/EBITDA | 0.08 |
| Current ratio | 3.31 |
| Quick ratio | 3.31 |